Treace Medical Concepts, Inc. Liabilities, Fair Value Adjustment
Treace Medical Concepts, Inc. (TMCI) reported Liabilities, Fair Value Adjustment of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes
us-gaap:LiabilitiesFairValueAdjustment · last filed 2025-02-27
- Treace Medical Concepts, Inc. liabilities, fair value adjustment for the quarter ending 2023-12-31 was $0.00.
- Treace Medical Concepts, Inc. liabilities, fair value adjustment for the quarter ending 2023-09-30 was $0.00.
- Treace Medical Concepts, Inc. liabilities, fair value adjustment for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Treace Medical Concepts, Inc. liabilities, fair value adjustment for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Treace Medical Concepts, Inc. liabilities, fair value adjustment for fiscal 2024 was $0.00.
- Treace Medical Concepts, Inc. liabilities, fair value adjustment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Treace Medical Concepts, Inc. liabilities, fair value adjustment for fiscal 2022 was $173.00K, a 140.28% increase from fiscal 2021.
- Treace Medical Concepts, Inc. liabilities, fair value adjustment for fiscal 2021 was $72.00K.
| Period end | Liabilities, Fair Value Adjustment 3 month | Liabilities, Fair Value Adjustment 6 month | Liabilities, Fair Value Adjustment 9 month | Liabilities, Fair Value Adjustment 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $83.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $83.00K derived: sum of 3 quarters · filed 2025-02-27 | $173.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $83.00K derived: sum of 2 quarters · filed 2023-11-09 | $173.00K 10-Q · filed 2023-11-09 | $173.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $173.00K 10-Q · filed 2023-08-09 | $173.00K derived: sum of 3 quarters · filed 2024-02-27 | $273.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $90.00K 10-Q · filed 2023-05-09 | $90.00K derived: sum of 2 quarters · filed 2024-02-27 | $190.00K derived: sum of 3 quarters · filed 2024-02-27 | $190.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $100.00K derived: sum of 2 quarters · filed 2024-02-27 | $100.00K derived: sum of 3 quarters · filed 2024-02-27 | $72.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | $100.00K 10-Q · filed 2021-11-04 | $100.00K derived: sum of 2 quarters · filed 2021-11-04 | $72.00K 10-Q · filed 2022-11-09 | $100.00K derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | $0.00 10-Q · filed 2022-08-10 | $0.00 derived: sum of 3 quarters · filed 2023-03-08 | $0.00 derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-08 | $0.00 derived: sum of 3 quarters · filed 2023-03-08 | $0.00 derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $0.00 derived: sum of 2 quarters · filed 2023-03-08 | $0.00 derived: sum of 3 quarters · filed 2023-03-08 | $0.00 10-K · filed 2023-03-08 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |